Whalesbook
Star Health and Allied Insurance Company Ltd announced on April 6, 2026, that it has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the transmission of 8,28,82,958 equity shares. These shares were previously held by the late investor Rakesh Jhunjhunwala. This regulatory clearance is a significant step in managing the investor's estate and clarifies a large shareholding block.
Significance of the Approval
The IRDAI approval is a vital step in formalizing the inheritance of a substantial stake in Star Health. It provides much-needed clarity on the ownership of these shares, a key part of Rakesh Jhunjhunwala's investment portfolio, and shows progress in settling his estate. For Star Health, it means regulatory consent for this significant ownership change, though it does not directly impact the company's operations or management.
Rakesh Jhunjhunwala's Stake in Star Health
Star Health, established in 2006 as India's first standalone health insurer, has become a major player in the sector. Rakesh Jhunjhunwala was a key promoter and investor, holding a substantial stake. As of January 2022, his personal shareholding was 14.40%, amounting to 8,28,82,958 shares, with his wife Rekha Jhunjhunwala. Together, they owned about 17.51% of the company. Jhunjhunwala was part of a consortium that agreed to acquire the company in 2018 for ₹6,500 crore. He passed away in August 2022, and his estate is now being managed by his family and professional executors. Star Health made its stock market debut on December 10, 2021.
Impact of the Transmission
The formal transmission of these 8.28 crore shares will officially update Star Health's shareholding records to reflect the transfer to legal heirs, as per Rakesh Jhunjhunwala's will. This approval is a key procedural milestone for managing and distributing the late investor's assets. The share transmission itself is an ownership event and will not immediately alter Star Health's daily business operations or management structure.
Past Regulatory Concerns for Star Health
While this development concerns share transmission, Star Health has faced regulatory challenges. The company has been under IRDAI scrutiny, receiving show cause notices for alleged violations in late 2024. In July 2025, IRDAI fined the insurer ₹3.39 crore for breaches in data safeguarding and cybersecurity guidelines. IRDAI also reviewed claim settlement practices early in 2025 following media reports of alleged lapses. Additionally, an investigation into alleged data breaches involving customer information occurred in late 2024. These past issues mean Star Health must maintain strict compliance and strong data security.
Competitors in the General Insurance Market
Star Health operates in India's competitive general insurance market. Its key competitors include other listed entities such as ICICI Lombard General Insurance, Bajaj Allianz General Insurance, HDFC ERGO General Insurance, and Go Digit General Insurance, all of which offer various insurance products.
Key Shareholding Metrics
As of March 31, 2021, Rakesh Jhunjhunwala's average acquisition cost for his Star Health shares was ₹156 per equity share. By January 14, 2022, the value of his Star Health holdings was estimated at over ₹8,300 crore.
Future Focus for Investors
Investors will be watching for the formal completion of the share transfer process and its reflection in updated shareholding patterns. They will also track the actions taken by beneficiaries or estate managers regarding these shares, Star Health's continued adherence to regulatory norms and operational efficiency, and the broader market reaction to this clarified ownership.